Key Highlights
•
A new expert consensus provides guidance on how to prevent relapse in patients with major depression after successful electroconvulsive therapy (ECT). This is crucial because while ECT is highly effective, patients are at high risk of depression returning without a clear plan for ongoing care.
Source →
•
Major international guidelines now recommend a procedure called renal denervation as an add-on treatment for patients whose high blood pressure remains uncontrolled despite medication. This offers a new, durable option for millions of people with hard-to-treat hypertension.
Source →
•
A large study found that for children with a type of chronic eye inflammation not linked to arthritis, starting treatment with the drug adalimumab was more effective at achieving remission than starting with the standard drug methotrexate. This suggests a potential shift in the first-choice treatment, especially for more severe forms of the disease.
Source →
•
A study analyzing birth defect severity linked periconceptional use of certain opioid-containing pain medications (like hydrocodone and codeine combined with acetaminophen) to a higher risk of severe, life-threatening birth defects. This research helps clarify which pain relief options carry higher risks during early pregnancy.
Source →
•
Researchers have developed a standardized tool to assess how well hospitals in low-resource settings are prepared for chemical, biological, radiological, or nuclear (CBRN) incidents. This is vital for countries like Lebanon, which are at high risk, to identify gaps and strengthen their emergency response capabilities.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
